The following articles (labelled with PubMed ID or TBD) are for your review
||MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A Inhibitors.
||Takeda Pharmaceuticals International Co. , 40 Landsdowne Street, Cambridge, Massachusetts 02139, United States.
||Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors.
||Sun Yat-sen University
||Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase.
||Millennium Pharmaceuticals Inc.
||Active site ring-opening of a thiirane moiety and picomolar inhibition of gelatinases.
||University of Notre Dame